Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC vs FEC Followed by Paclitaxel +/- Pegfilgrastim in Node-Positive Breast Cancer
NCT00433420Phase 3Active, not recruiting
- Start
- Apr 2003
- Primary completion
- May 2006
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 3 trial of fluorouracil, pegfilgrastim in breast cancer. Started Apr 2003; status: active, not recruiting.
02
Drugs
fluorouracilpegfilgrastim
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00433420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433420.